| Ytd | -14.63% | |
| 1y | -82.84% |
| Open | Prev Close | 0.64 | Low | High | Mkt Cap | 22.49M | |||
| Vol | 0.00 | Avg Vol | 171.28K | EPS | -1.44 | P/E | -0.44 | Forward P/E | -2.27 |
| Beta | 2.94 | Short Ratio | 10.06 | Inst. Own | 86.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 0.74 | 200-d Avg | 0.98 | 1yr Est | 18.00 |
SKYE News
On June 18, 2026, the Company received approval from the Staff to transfer the listing of the Compan
SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ: SKYE), a clinical-stage b
SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye” or the “Com
SAN DIEGO, May 11, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye” or the “Com
NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is
SAN DIEGO, April 07, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinic
Topline safety and pharmacokinetic data expected in Q4 2026; an independent Data Monitoring Committe
Domo Inc (DOMO) stock jumped 48.8% in pre-market trading after beating Q4 earnings expectations by 1
Skye Bioscience, Inc. (SKYE) Q4 2025 Earnings Call Transcript
SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ: SKYE) (“Skye” or the “C
SAN DIEGO, March 05, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clini
Shares of Skye Bioscience, Inc. (NASDAQ: SKYE - Get Free Report) have been given a consensus recomme
Skye Bioscience, Inc. (NASDAQ: SKYE) on Monday shared interim 52-week data from the combination ther
22.3% total weight loss at 52 weeks with nimacimab (200 mg dose) + semaglutide (2.4 mg) combination
SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinica
SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinica
NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i
Shares of Skye Bioscience, Inc. (NASDAQ: SKYE - Get Free Report) have been given an average recommen
LOS ANGELES, Jan. 19, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action law
LOS ANGELES, Jan. 19, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights liti
NEW YORK, Jan. 16, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, rem
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
GAINERS: Red White & Bloom Brands (OTC: RWBYF) shares closed up 300.00% at $0.04